Latest News

Severe Maternal Morbidity Can Adversely Affect Mental Health


 

TOPLINE:

Individuals with severe maternal morbidity (SMM) are at an increased risk for mental health condition–related hospitalization or emergency department (ED) visits up to 13 years after delivery.

METHODOLOGY:

  • This retrospective cohort study compared mental health hospitalizations and ED visits in postpartum individuals with and without SMM over 13 years after delivery from April 2008 to March 2021.
  • The study analyzed 1,579,392 individuals aged 18-55 years with a first recorded liveborn or stillborn delivery from a pregnancy lasting 20-43 weeks, of which 35,825 (2.3%) had exposure to SMM.
  • The SMM exposure was analyzed for events occurring after 20 weeks’ gestation and up to 42 days after delivery hospital discharge in the first recorded birth; those without SMM were considered unexposed.
  • The main outcome was a combination of mental health hospitalizations or ED visits occurring at least 43 days after the index birth hospitalization.

TAKEAWAY:

  • Individuals with SMM had a 1.3-fold increased risk of mental health hospitalizations or ED visits.
  • The hospital or ED visits per 10,000 person-years were 59.2 for mood and anxiety disorders, 17.1 for substance abuse and related disorders, 4.8 for suicidality or self-harm, and 4.1 for schizophrenia spectrum or other psychotic disorders.
  • Following SMM, an elevated risk was observed for all mental health outcomes except one (schizophrenia spectrum and other psychotic disorders), with the highest risk seen for suicidality and self-harm (aHR, 1.54).

IN PRACTICE:

“Knowledge of the short- and long-term risks of serious mental health conditions after SMM and its subtypes could inform the need for enhanced postpartum supportive resources,” the authors wrote.

SOURCE:

This study was led by Asia Blackman, MSc, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada. It was published online in JAMA Network Open.

LIMITATIONS:

The study is limited by its observational design, missing data, and misclassification bias.

DISCLOSURES:

This study was supported by funding from the Canadian Institutes of Health Research. Three authors reported receiving personal fees or grants outside the submitted work. No other conflicts of interest were reported.

A version of this article first appeared on Medscape.com.

Recommended Reading

Toward a better framework for postmarketing reproductive safety surveillance of medications
MDedge Psychiatry
Perinatal Psychiatry in 2024: Helping More Patients Access Care
MDedge Psychiatry
Autoimmune Diseases and Perinatal Depression May Share Two-Way Link
MDedge Psychiatry
Buprenorphine Slightly Less Risky than Methadone for Fetal Malformation
MDedge Psychiatry
Lying-in No Longer: Staying Active Key to Healthy Pregnancy
MDedge Psychiatry
FDA Removes Harmful Chemicals From Food Packaging
MDedge Psychiatry
Paid Parental Leave: Impact on Maternal Mental Health and Child Wellbeing
MDedge Psychiatry
Perinatal Mood and Anxiety Disorder Increasing Rapidly
MDedge Psychiatry
Premenstrual Disorders and Perinatal Depression: A Two-Way Street
MDedge Psychiatry
Esketamine Linked to Reduced Postpartum Depression Risk
MDedge Psychiatry